Regeneron Pharmaceuticals Inc. said on Thursday that an antibody therapy frequently used in unvaccinated COVID-19 patients has “diminished” potency against the omicron variant. “While Regeneron’s currently authorized REGEN-COV antibodies…
Copyright © 2024 | WordPress Theme by MH Themes
